Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
Holding CLDX?
Track your performance easily

Celldex (CLDX) Financial Statements

1,006 Followers

Celldex Financial Overview

Celldex's market cap is currently ―. The company's EPS TTM is $-2.742; its P/E ratio is -15.26; Celldex is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.50M$ 156.00K$ 4.13M$ 1.52M$ 268.00K
Gross Profit$ 2.50M$ 156.00K$ 4.13M$ 1.52M$ 268.00K
EBIT$ -35.84M$ -40.61M$ -35.13M$ -38.26M$ -30.50M
EBITDA$ -31.73M$ -39.83M$ -34.37M-$ -30.91M
Net Income Common Stockholders$ -35.84M$ -32.81M$ -43.31M$ -38.26M$ -30.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 802.32M$ 823.85M$ 423.60M$ 235.35M$ 252.70M
Total Assets$ 845.59M$ 868.85M$ 465.63M$ 280.26M$ 299.31M
Total Debt$ 2.38M$ 2.11M$ 2.54M$ 2.85M$ 3.25M
Net Debt$ -799.93M$ -821.73M$ -421.06M$ -232.50M$ -249.44M
Total Liabilities$ 31.93M$ 30.23M$ 36.46M$ 33.54M$ 21.77M
Stockholders Equity$ 813.66M$ 838.61M$ 429.17M$ 246.72M$ 277.54M
Cash Flow-
Free Cash Flow$ -29.67M$ -40.94M$ -33.20M-$ -27.61M
Operating Cash Flow$ -29.40M$ -40.60M$ -32.53M$ -19.00M$ -27.20M
Investing Cash Flow$ -46.72M$ -315.21M$ -171.16M$ 11.65M$ 1.16M
Financing Cash Flow$ 3.71M$ 436.11M$ 217.37M$ 257.00K$ 133.00K
Currency in USD

Celldex Earnings and Revenue History

Celldex Debt to Assets

Celldex Cash Flow

Celldex Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis